SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a private debt exchange that effectively converted $1.4 billion of senior notes into equity, a move that the community is actively debating as either a strategic balance sheet cleanup to prepare for potential M&A or as an act of shareholder dilution. Traders are closely monitoring the 35-day volume-weighted average price window for this exchange, while retail sentiment remains deeply polarized between those betting on long-term acquisition catalysts and others expressing frustration over the stock's persistent price stagnation.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee continues to drive intense community conversation around its massive store expansion and solid quarterly revenue growth, fueling persistent speculation about a potential future relisting. Investors are actively debating the company's long-term competitive positioning against rivals, while monitoring the ongoing share repurchase program and its impact on price stability.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investor optimism builds around strong commercial momentum for Briumvi and the expansion into new indications like schizophrenia and myasthenia gravis. The community is actively discussing the potential for a long-term buyout and the ongoing frustration with analyst price targets that lag behind the company's growth trajectory and pipeline development.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is facing significant downward pressure as investors brace for the upcoming quarterly earnings release and the imminent expiration of a major insider lock-up period that threatens to flood the market with millions of shares. While the community is deeply divided between long-term believers citing the company's ambitious space infrastructure goals and bears warning of extreme valuation concerns and potential dilution, the stock remains highly volatile with intense focus on how the market will absorb the looming supply overhang.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is trending as investors digest news of a potential mega-merger with AstraZeneca, a move that would reshape the pharmaceutical landscape and significantly consolidate oncology assets. The community is actively debating the strategic merits of such a deal, specifically focusing on the massive cost-cutting synergies and the necessity of shoring up a pipeline facing significant patent expirations.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is trending following reports that the company has secured a three-year tariff reprieve from the U.S. government by committing to significant domestic manufacturing investments and steep price discounts. Investors and market participants are actively discussing the implications of this major strategic move on the company's long-term margin profile and its competitive standing within the pharmaceutical sector.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

SPRY is trending as investors react to a leadership transition and a challenging commercial environment, with the community actively debating whether the companys recent operational struggles represent a buying opportunity or a deeper failure. Meanwhile, participants are fixated on how these challenges compare to competitors in the needle-free epinephrine space.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Walt Disney Co. is trending as investors weigh strong theatrical box office performance from major intellectual property releases against broader media sector volatility, while the community remains divided over its long-term streaming strategy and the potential impact of corporate restructuring rumors.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is trending as investors react to strong quarterly earnings that topped analyst expectations alongside a massive contracted backlog that underscores demand for their domestic manufacturing. The community is actively discussing the stock's breakout potential as it clears major technical hurdles, despite some ongoing volatility and debates regarding sector-wide policy impacts.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is seeing heightened trading volume and sentiment volatility as investors weigh the company's aggressive growth narrative against valuation concerns ahead of the upcoming earnings release. The community remains deeply divided, with bulls pointing to the company's massive contract expansion and AI integration as key catalysts for a rebound, while bears maintain focus on the stock's high valuation multiples and the potential for a sell-the-news reaction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lowest Volume Rated ETFs Per 4/9/2025’s Close:

1 – $FDVL

2 – $GVUS

3 – $CCNR

4 – $FDGR

5 – $PSCX

6 – $ISEP

7 – $BBEM

8 – $RSSE

9 – $SECR

10 – $VNSE

https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-4-9-2025/

The VIX closed at 33.62, indicating an implied one day move of +/-2.12% & an implied one month move of +/-9.72% for the S&P 500.